Determination of the carbapenem resistance in Escherichia coli isolated from samples obtained from Shahrekord hospitals and determination of their minimum inhibitory concentration
Open Access
- 31 December 2019
- journal article
- Published by Maad Rayan Publishing Company in Journal of Shahrekord University of Medical Sciences
- Vol. 21 (6) , 280-283
Abstract
Background and aims:Carbapenems are the final-line treatments for multidrug-resistant, gram-negative infections. The patterns of resistance to carbapenems among hospital bacterial pathogens vary widely across different hospitals in a country. Considering that Escherichia coli is one of the most important causes of nosocomial infections, it is essential to study its drug resistance.Methods:In this descriptive-analytical study, a total of 80 samples of E. coli isolated from inpatients with urinary tract infections (UTIs) were collected in different wards (i.e., women, urology, infectious, and ICU) of Shahrekord hospitals. After the diagnosis and confirmation of bacteria by standard bacteriological methods, their sensitivity to imipenem and meropenem was investigated by the antibiogram (diskdiffusion) method. Then, the minimum inhibitory concentration (MIC) was determined by the E-test strip according to the Clinical and Laboratory Standards Institute (CLSI) standard.Results:In this study, resistance to meropenem and imipenem by antibiogram (disc diffusion) was observed in 21 (25.26%) and 20 (25%) of the isolates, respectively. Twenty isolates had MIC ≥4 μg/mL for meropenem, 13 isolates demonstrated MIC≥4 μg/mL for imipenem, and 14 isolates had 1≤MICConclusion:In general, E. coli had significant resistance to carbapenems. Therefore, rapid and accurate identification of these strains can be a major step to the treatment and control of these strains and prevention of the spread of the resistance.Keywords
This publication has 23 references indexed in Scilit:
- Decreasing Catheter-Associated Urinary Tract Infections in the Neurological Intensive Care Unit: One Unit’s SuccessCritical Care Nurse, 2017
- Risk Factors for Bacteremia in Patients With Urinary Catheter–Associated BacteriuriaAmerican Journal of Critical Care, 2016
- Outbreak of IMP-producing carbapenem-resistantEnterobacter gergoviaeamong kidney transplant recipientsJournal of Antimicrobial Chemotherapy, 2016
- Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral AntibioticsAntimicrobial Agents and Chemotherapy, 2016
- Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, ChinaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2015
- Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolatesInternational Journal of Antimicrobial Agents, 2011
- Emerging carbapenemases: a global perspectiveInternational Journal of Antimicrobial Agents, 2010
- Prevention of hospital-acquired infections: review of non-pharmacological interventionsJournal of Hospital Infection, 2008
- Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countriesAmerican Journal of Infection Control, 2008
- Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo- -lactamase: first Italian outbreakJournal of Antimicrobial Chemotherapy, 2007